Epstein David M. 4
4 · GYRE THERAPEUTICS, INC. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Epstein David M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+26,000→ 26,000 totalExercise: $8.58Exp: 2035-06-04→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.